Jonas Denecke

Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen Within the Expanded Access Program in Germany

Abstract: Background: Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by muscle weakness and muscle atrophy. Nusinersen acts a...